Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DB25FS6FU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $34,986
Award facts
- Contract value 100% obligated
- $34,986.35 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $34,986.35 to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) 300mg dose in 2-pen/ml configuration. This contract was competitively awarded with no set-aside designation and is classified as a firm fixed-price delivery order, with an ultimate completion date of August 22, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. The award represents a single delivery order under the company's broader pharmaceutical supply relationships with the federal government.
This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026 that enables the company to supply pharmaceutical products and medical supplies globally to support military healthcare programs. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp regularly fulfills delivery orders for brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This particular order for Cosentyx, an immunosuppressive medication used to treat autoimmune conditions, reflects the company's role in supporting the medical supply chain for military and veteran healthcare needs.
Quick answers
Who was awarded contract SPE2DB25FS6FU?
SPE2DB25FS6FU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 21, 2025.
How much is contract SPE2DB25FS6FU worth?
The government has obligated $34,986 on SPE2DB25FS6FU.
Is contract SPE2DB25FS6FU an order under another contract?
Yes. SPE2DB25FS6FU is a delivery order under SPE2DB22D2214, an indefinite delivery contract.
Was contract SPE2DB25FS6FU competed?
The extent of competition for SPE2DB25FS6FU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award